Published Date: 08 Mar 2023
A groundbreaking study by the University of Bristol and the University of Essex has revealed new insights into the importance of early childhood for lung health.
Read Full NewsDupilumab significantly improves sinus opacification and disease burden in patients with allergic fungal rhinosinusitis.
Oral fecal microbiota transplant raises the amount of peanut that some highly allergic adults can tolerate, serving as proof of concept for microbiome-based food allergy therapy.
Dupilumab yields sustained benefits in terms of nasal congestion, sense of smell, and quality of life in patients with CRSwNP over 24 months in a real-world global registry.
Adults with childhood-onset systemic lupus erythematosus face a strikingly different disease trajectory than those diagnosed later in life, spending less time in the low disease activity state.
Acarizax is now the first house dust mite immunotherapy accepted by the SMC for patients with persistent allergic rhinitis.
1.
France Expands 2026 Vaccination Rules Amid Resurgence
2.
Cancer Warnings on Alcohol? Surge in GI Illnesses; Swab Detects Kids' Asthma Type
3.
Booze and Pancreatic Cancer Risk; From 'Hospice' to 'Hope'; Gen Z-ers Skip Screening
4.
Dementia-like protein buildup found in pancreas cells before cancer develops
5.
Combination Treatment May Improve Multiple Myeloma Outcomes
1.
Cancer in 2024: Global Trends, Challenges, and Innovations for Healthcare Professionals
2.
Demystifying Lymphocytes: Everything You Need to Know
3.
The Growing Challenge of Haematological Malignancies in Older Adults
4.
Unlocking the Mystery of Granulomas: A Closer Look at the Causes and Treatment
5.
Understanding Apoplexy: Symptoms, Causes, and Treatment Options
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
1.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
2.
Efficient Management of First line ALK-rearranged NSCLC - Part VI
3.
Current Scenario of Cancer- The Incidence of Cancer in Men
4.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
5.
Thromboprophylaxis In Medical Settings
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation